文献速递肝病

联合CRP与vWF-Ag可提升MELD-Na对等待名单死亡率的预测

The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
PubMed 文献 · Hepatology · 2021-08-29

该研究在维也纳探索队列(n=269)和梅奥验证队列(n=129)中评估将C反应蛋白(CRP)与血管性血友病因子抗原(vWF-Ag)加入MELD-Na是否改善等待名单死亡风险分层。结果显示联合加入后3个月等待名单死亡率预测的ROC-AUC在探索队列从0.764升至0.824,验证队列从0.677升至0.882。

要点

  • 联合CRP与vWF-Ag可提升MELD-Na对3个月等待名单死亡率的预测
  • vWF-Ag独立关联门静脉高压与炎症标志物
  • CRP关联细菌易位/炎症标志物

核心结论

  • 将反映门静脉高压、细菌易位和炎症的vWF-Ag与CRP加入MELD-Na可改善等待名单死亡率预测。

研究设计与样本

  • 在两个独立队列中于肝移植登记时检测CRP与vWF-Ag并记录临床特征、MELD-Na及等待名单死亡率:维也纳探索队列n=269,梅奥验证队列n=129。

主要发现

  • 探索队列中3个月等待名单死亡率预测的ROC-AUC:MELD-Na为0.764,MELD-Na+CRP为0.790,MELD-Na+vWF为0.803,MELD-Na+CRP+vWF-Ag为0.824。
  • 验证队列中3个月等待名单死亡率预测的ROC-AUC:MELD-Na为0.677,MELD-Na+CRP+vWF-Ag为0.882。
  • vWF-Ag独立关联门静脉高压和炎症生物标志物;CRP与细菌易位/炎症标志物密切相关;MELD与这些标志物独立相关。

关键数值与推荐

  • 3个月等待名单死亡率预测的ROC-AUC在探索队列为MELD-Na 0.764、MELD-Na+CRP 0.790、MELD-Na+vWF 0.803、MELD-Na+CRP+vWF-Ag 0.824。
  • 验证队列3个月等待名单死亡率预测的ROC-AUC为MELD-Na 0.677、MELD-Na+CRP+vWF-Ag 0.882。

临床怎么用

  • 考虑在MELD-Na基础上联合CRP与vWF-Ag以改善肝移植等待名单死亡风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients with cirrhosis on the liver transplant (LT) waiting list may die or be removed because of complications of portal hypertension (PH) or infections. von Willebrand factor antigen (vWF-Ag) and C-reactive protein (CRP) are simple, broadly available markers of these processes. APPROACH AND RESULTS: We determined whether addition of vWF-Ag and CRP to the Model for End-Stage Liver Disease-Sodium (MELD-Na) score improves risk stratification of patients awaiting LT. CRP and vWF-Ag at LT listing were assessed in two independent cohorts (Medical University of Vienna [exploration cohort] and Mayo Clinic Rochester [validation cohort]). Clinical characteristics, MELD-Na, and mortality on the waiting list were recorded. Prediction of 3-month waiting list mortality was assessed by receiver operating characteristics curve (ROC-AUC). In order to explore potential mechanisms underlying the prognostic utility of vWF-Ag and CRP in this setting, we evaluated their association with PH, bacterial translocation, systemic inflammation, and circulatory dysfunction. In the exploration cohort (n = 269) vWF-Ag and CRP both improved the predictive value of MELD-Na for 3-month waitlist mortality and showed the highest predictive value when combined (AUC: MELD-Na, 0.764; MELD-Na + CRP, 0.790; MELD-Na + vWF, 0.803; MELD-Na + CRP + vWF-Ag, 0.824). Results were confirmed in an independent validation cohort (n = 129; AUC: MELD-Na, 0.677; MELD-Na + CRP + vWF-Ag, 0.882). vWF-Ag was independently associated with PH and inflammatory biomarkers, whereas CRP closely, and MELD independently, correlated with biomarkers of bacterial translocation/inflammation. CONCLUSIONS: The addition of vWF-Ag and CRP-reflecting central pathophysiological mechanisms of PH, bacterial translocation, and inflammation, that are all drivers of mortality on the waiting list for LT-to the MELD-Na score improves prediction of waitlist mortality. Using the vWFAg-CRP-MELD-Na model for prioritizing organ allocation may improve prediction of waitlist mortality and decrease waitlist mortality.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Starlinger P, Ahn JC, Mullan A, et al. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality. Hepatology. 2021. PMID: 33786862. doi:10.1002/hep.31838

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。